Similar articles

• Conjugated estrogens/bazedoxifene (Duavee) for menopausal symptoms and prevention of osteoporosis.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2014 Apr 28;56(1441):33-4. Med Lett Drugs Ther. 2014. PMID: 24759293 No abstract available.
• Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.

  Komm BS, Mirkin S, Jenkins SN. Komm BS, et al. Steroids. 2014 Nov;90:71-81. doi: 10.1016/j.steroids.2014.06.004. Epub 2014 Jun 11. Steroids. 2014. PMID: 24929044 Review.
• Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.

  Lewiecki EM. Lewiecki EM. Expert Opin Investig Drugs. 2007 Oct;16(10):1663-72. doi: 10.1517/13543784.16.10.1663. Expert Opin Investig Drugs. 2007. PMID: 17922629 Review.
• Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.

  Mirkin S, Ryan KA, Chandran AB, Komm BS. Mirkin S, et al. Maturitas. 2014 Jan;77(1):24-31. doi: 10.1016/j.maturitas.2013.10.009. Epub 2013 Oct 25. Maturitas. 2014. PMID: 24246155 Review.
• Tissue-selective estrogen complexes for postmenopausal women.

  Mirkin S, Komm BS. Mirkin S, et al. Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11. Maturitas. 2013. PMID: 23849704 Review.